A Systematic Review of Statin Efficacy in Asthma

References

• Arnaud C, Braunersreuther V, Mach F. Toward immunomodulatory and anti-inflammatory properties of statins. Trends Cardiovasc Med 2005; 15(6):202–206.
   PubMed Web of Science ®Google Scholar
• Smith SC Jr, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, Grundy SM, Hiratzka L, Jones D, Krumholz HM, Mosca L, Pasternak RC, Pearson T, Pfeffer MA, Taubert KA. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006; 113(19):2363–2372.
   PubMed Web of Science ®Google Scholar
• Chow SC. Immunomodulation by statins: mechanisms and potential impact on autoimmune diseases. Arch Immunol Ther Exp (Warsz) 2009; 57(4):243–251.
   Google Scholar
• Smaldone C, Brugaletta S, Pazzano V, Liuzzo G. Immunomodulator activity of 3-hydroxy-3-methilglutaryl-CoA inhibitors. Cardiovasc Hematol Agents Med Chem 2009; 7(4):279–294.
   PubMedGoogle Scholar
• Bu DX, Griffin G, Lichtman AH. Mechanisms for the anti-inflammatory effects of statins. Curr Opin Lipidol 2011; 22(3):165–170.
   PubMed Web of Science ®Google Scholar
• Haldar P, Pavord ID, Shaw DE, Berry MA, Thomas M, Brightling CE, Wardlaw AJ, Green RH. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008; 178(3):218–224.
   PubMed Web of Science ®Google Scholar
• Moore WC, Meyers DA, Wenzel SE, Teague WG, Li H, Li X, D’Agostino R Jr, Castro M, Curran-Everett D, Fitzpatrick AM, Gaston B, Jarjour NN, Sorkness R, Calhoun WJ, Chung KF, Comhair SA, Dweik RA, Israel E, Peters SP, Busse WW, Erzurum SC, Bleecker ER; National Heart, Lung, and Blood Institute’s Severe Asthma Research Program. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med 2010; 181(4):315–323.
   PubMed Web of Science ®Google Scholar
• Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet 2006; 368(9537):804–813.
   PubMed Web of Science ®Google Scholar
• Bhakta NR, Woodruff PG. Human asthma phenotypes: from the clinic, to cytokines, and back again. Immunol Rev 2011; 242(1):220–232.
   Google Scholar
• Kim HY, DeKruyff RH, Umetsu DT. The many paths to asthma: phenotype shaped by innate and adaptive immunity. Nat Immunol 2010; 11(7):577–584.
   PubMed Web of Science ®Google Scholar
• Anderson GP. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet 2008; 372(9643):1107–1119.
   PubMed Web of Science ®Google Scholar
• Agache I, Akdis C, Jutel M, Virchow JC. Untangling asthma phenotypes and endotypes. Allergy 2012; 67(7):835–846.
   PubMed Web of Science ®Google Scholar
• Jeffery PK, Haahtela T. Allergic rhinitis and asthma: inflammation in a one-airway condition. BMC Pulm Med 2006; 6(Suppl 1):S5.
   PubMedGoogle Scholar
• Imamura M, Okunishi K, Ohtsu H, Nakagome K, Harada H, Tanaka R, Yamamoto K, Dohi M. Pravastatin attenuates allergic airway inflammation by suppressing antigen sensitisation, interleukin 17 production and antigen presentation in the lung. Thorax 2009; 64(1):44–49.
   PubMed Web of Science ®Google Scholar
• McKay A, Leung BP, McInnes IB, Thomson NC, Liew FY. A novel anti-inflammatory role of simvastatin in a murine model of allergic asthma. J Immunol 2004; 172(5):2903–2908.
   PubMed Web of Science ®Google Scholar
• Review Manager (RevMan) [Computer program]. Version 5.0. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008. Available from: http://ims.cochrane.org/revman/about-revman-5
   Google Scholar
• Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2009. Available from www.cochrane-handbook.org
   Google Scholar
• Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, Norris S, Falck-Ytter Y, Glasziou P, DeBeer H, Jaeschke R, Rind D, Meerpohl J, Dahm P, Schünemann HJ. GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 2011; 64(4):383–394.
   PubMed Web of Science ®Google Scholar
• Guyatt GH, Oxman AD, Kunz R, Atkins D, Brozek J, Vist G, Alderson P, Glasziou P, Falck-Ytter Y, Schünemann HJ. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol 2011; 64(4):395–400.
   PubMed Web of Science ®Google Scholar
• Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, Vist GE, Falck-Ytter Y, Meerpohl J, Norris S, Guyatt GH. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 2011; 64(4):401–406.
   PubMed Web of Science ®Google Scholar
• Guyatt GH, Oxman AD, Vist G, Kunz R, Brozek J, Alonso-Coello P, Montori V, Akl EA, Djulbegovic B, Falck-Ytter Y, Norris SL, Williams JW Jr, Atkins D, Meerpohl J, Schünemann HJ. GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias). J Clin Epidemiol 2011; 64(4):407–415.
   PubMed Web of Science ®Google Scholar
• Guyatt GH, Oxman AD, Schünemann HJ, Tugwell P, Knottnerus A. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol 2011; 64(4):380–382.
   PubMed Web of Science ®Google Scholar
• Huang CC, Chan WL, Chen YC, Chen TJ, Chou KT, Lin SJ, Chen JW, Leu HB. Statin use in patients with asthma—a nationwide population-based study. Eur J Clin Invest 2011; 41(5):507–512.
   PubMed Web of Science ®Google Scholar
• Braganza G, Chaudhuri R, McSharry C, Weir CJ, Donnelly I, Jolly L, Lafferty J, Lloyd SM, Spears M, Mair F, Thomson NC. Effects of short-term treatment with atorvastatin in smokers with asthma—a randomized controlled trial. BMC Pulm Med 2011; 11(1):16.
   PubMed Web of Science ®Google Scholar
• Maneechotesuwan K, Ekjiratrakul W, Kasetsinsombat K, Wongkajornsilp A, Barnes PJ. Statins enhance the anti-inflammatory effects of inhaled corticosteroids in asthmatic patients through increased induction of indoleamine 2, 3-dioxygenase. J Allergy Clin Immunol 2010; 126(4):754–762.e1.
   Google Scholar
• Cowan DC, Cowan JO, Palmay R, Williamson A, Taylor DR. Simvastatin in the treatment of asthma: lack of steroid-sparing effect. Thorax 2010; 65(10):891–896.
   PubMed Web of Science ®Google Scholar
• Ostroukhova M, Kouides RW, Friedman E. The effect of statin therapy on allergic patients with asthma. Ann Allergy Asthma Immunol 2009; 103(6):463–468.
   PubMed Web of Science ®Google Scholar
• Hothersall EJ, Chaudhuri R, McSharry C, Donnelly I, Lafferty J, McMahon AD, Weir CJ, Meiklejohn J, Sattar N, McInnes I, Wood S, Thomson NC. Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma. Thorax 2008; 63(12):1070–1075.
   PubMed Web of Science ®Google Scholar
• Fahimi F. Do statins improve lung function in asthmatic patients? A randomized and double blind trial. Iranian J Pharmaceut Sci 2009; 5(1):13–20.
   Google Scholar
• Menzies D, Nair A, Meldrum KT, Fleming D, Barnes M, Lipworth BJ. Simvastatin does not exhibit therapeutic anti-inflammatory effects in asthma. J Allergy Clin Immunol 2007; 119(2):328–335.
   PubMed Web of Science ®Google Scholar
• Zeki AA, Kenyon NJ, Yoneda K, Louie S. The adult asthmatic. Clin Rev Allergy Immunol 2012 Aug; 43(1–2):138–55.
   Google Scholar
• Zeki AA, Kenyon NJ, Goldkorn T. Statin drugs, metabolic pathways, and asthma: a therapeutic opportunity needing further research. Drug Metabol Lett 2011; 5(1):40–44.
   PubMedGoogle Scholar
• Schaafsma D, Dueck G, Ghavami S, Kroeker A, Mutawe MM, Hauff K, Xu FY, McNeill KD, Unruh H, Hatch GM, Halayko AJ. The mevalonate cascade as a target to suppress extracellular matrix synthesis by human airway smooth muscle. Am J Respir Cell Mol Biol 2011; 44(3):394–403.
   PubMed Web of Science ®Google Scholar
• Pawlak J, Zietkowski Z, Bodzenta-Lukaszyk A. [Beta-blockers and statins in the context of asthma]. Postepy Hig Med Dosw (Online) 2009; 63:634–642.
   Google Scholar
• Royce SG, Tang ML. The effects of current therapies on airway remodeling in asthma and new possibilities for treatment and prevention. Curr Mol Pharmacol 2009; 2(2):169–181.
   PubMedGoogle Scholar
• Robinson AJ, Kashanin D, O’Dowd F, Fitzgerald K, Williams V, Walsh GM. Fluvastatin and lovastatin inhibit granulocyte macrophage-colony stimulating factor-stimulated human eosinophil adhesion to inter-cellular adhesion molecule-1 under flow conditions. Clin Exp Allergy 2009; 39(12):1866–1874.
   PubMed Web of Science ®Google Scholar
• Shyamsundar M, McKeown ST, O’Kane CM, Craig TR, Brown V, Thickett DR, Matthay MA, Taggart CC, Backman JT, Elborn JS, McAuley DF. Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers. Am J Respir Crit Care Med 2009; 179(12):1107–1114.
   PubMed Web of Science ®Google Scholar
• Feldman C. The role of statins in respiratory diseases. Clin Pulm Med 2009; 16(2):95–100.
   Google Scholar
• Rubin BK. Statins for the treatment of asthma: a discovery well, dry hole or just snake oil. Thorax 2009; 64(1):4–5.
   PubMed Web of Science ®Google Scholar
• Camoretti-Mercado B. Targeting the airway smooth muscle for asthma treatment. Transl Res 2009; 154(4):165–174.
   Google Scholar
• Al Obaidi AHA, Al Samarai AGM. Evaluation anti-inflammatory and anti-oxidant activity of simvastatin in asthma. J Bahrain Med Soc 2008; 20(2):55–59.
   Google Scholar
• Walsh GM. Defective apoptotic cell clearance in asthma and COPD—a new drug target for statins? Trends Pharmacol Sci 2008; 29(1):6–11.
   Google Scholar
• Paraskevas KI, Tzovaras AA, Briana DD, Mikhailidis DP. Emerging indications for statins: a pluripotent family of agents with several potential applications. Curr Pharm Des 2007; 13(35):3622–3636.
   PubMed Web of Science ®Google Scholar
• Takizawa H. Novel strategies for the treatment of asthma. Recent Pat Inflamm Allergy Drug Discov 2007; 1(1):13–19.
   Google Scholar
• Ennis M. New targets for modifying mast cell activation in asthma. Curr Allergy Asthma Rep 2006; 6(3):247–251.
   Google Scholar
• Ennis M. New therapeutic interventions in airway inflammatory and allergic diseases. Anti-Inflamm AntiAllergy Agents Med Chem 2006; 5(4):353–356.
   Google Scholar
• Samson KT, Minoguchi K, Tanaka A, Oda N, Yokoe T, Yamamoto Y, Yamamoto M, Ohta S, Adachi M. Inhibitory effects of fluvastatin on cytokine and chemokine production by peripheral blood mononuclear cells in patients with allergic asthma. Clin Exp Allergy 2006; 36(4):475–482.
   PubMed Web of Science ®Google Scholar
• Hillas G, Kostikas K, Mantzouranis K, Bessa V, Kontogianni K, Papadaki G, Papiris S, Alchanatis M, Loukides S, Bakakos P. Exhaled nitric oxide and exhaled breath condensate pH as predictors of sputum cell counts in optimally treated asthmatic smokers. Respirology 2011; 16(5):811–818.
   PubMed Web of Science ®Google Scholar
• Hothersall E, McSharry C, Thomson NC. Potential therapeutic role for statins in respiratory disease. Thorax 2006; 61(8):729–734.
   PubMed Web of Science ®Google Scholar
• Hakamada-Taguchi R, Uehara Y, Kuribayashi K, Numabe A, Saito K, Negoro H, Fujita T, Toyo-oka T, Kato T. Inhibition of hydroxymethylglutaryl-coenzyme a reductase reduces Th1 development and promotes Th2 development. Circ Res 2003; 93(10):948–956.
   Google Scholar
• Coward W, Chow SC. Effect of atorvastatin on TH1 and TH2 cytokine secreting cells during T cell activation and differentiation. Atherosclerosis 2006; 186(2):302–309.
   Google Scholar
• Zhang X, Markovic-Plese S. Statins’ immunomodulatory potential against Th17 cell-mediated autoimmune response. Immunol Res 2008; 41(3):165–174.
   Google Scholar
• Kim DY, Ryu SY, Lim JE, Lee YS, Ro JY. Anti-inflammatory mechanism of simvastatin in mouse allergic asthma model. Eur J Pharmacol 2007; 557(1):76–86.
   PubMed Web of Science ®Google Scholar
• Zeki AA, Bratt JM, Rabowsky M, Last JA, Kenyon NJ. Simvastatin inhibits goblet cell hyperplasia and lung arginase in a mouse model of allergic asthma: a novel treatment for airway remodeling? Transl Res 2010; 156(6):335–349.
   PubMed Web of Science ®Google Scholar
• Zeki AA, Franzi L, Last J, Kenyon NJ. Simvastatin inhibits airway hyperreactivity: implications for the mevalonate pathway and beyond. Am J Respir Crit Care Med 2009; 180(8):731–740.
   PubMed Web of Science ®Google Scholar
• El-Haibi C, Rahal E, Khauli RB, Abdelnoor AM. Effect of atorvastatin on antibody, interleukin-4 and gamma-interferon production in mice immunized with egg albumin. Immunopharmacol Immunotoxicol 2006; 28(3):459–470.
   PubMed Web of Science ®Google Scholar
• Yeh YF, Huang SL. Enhancing effect of dietary cholesterol and inhibitory effect of pravastatin on allergic pulmonary inflammation. J Biomed Sci 2004; 11(5):599–606.
   Google Scholar
• Chiba Y, Sato S, Misawa M. Upregulation of geranylgeranyltransferase I in bronchial smooth muscle of mouse experimental asthma: its inhibition by lovastatin. J Smooth Muscle Res 2010; 46(1):57–64.
   Google Scholar
• Chiba Y, Sato S, Misawa M. Inhibition of antigen-induced bronchial smooth muscle hyperresponsiveness by lovastatin in mice. J Smooth Muscle Res 2008; 44(3–4):123–128.
   Google Scholar
• Ahmad T, Mabalirajan U, Sharma A, Aich J, Makhija L, Ghosh B, Agrawal A. Simvastatin improves epithelial dysfunction and airway hyperresponsiveness: from asymmetric dimethyl-arginine to asthma. Am J Respir Cell Mol Biol 2011; 44(4):531–539.
   PubMed Web of Science ®Google Scholar
• Agrawal A, Mabalirajan U, Ahmad T, Ghosh B. Emerging interface between metabolic syndrome and asthma. Am J Respir Cell Mol Biol 2011; 44(3):270–275.
   PubMed Web of Science ®Google Scholar
• Ramalho R, Almeida J, Beltrão M, Pirraco A, Costa R, Sokhatska O, Guardão L, Palmares C, Guimarães JT, Delgado L, Moreira A, Soares R. Neurogenic inflammation in allergen-challenged obese mice: a missing link in the obesityasthma association? Exp Lung Res 2012; 38(6): 316–24.
   PubMed Web of Science ®Google Scholar
• Matera MG, Calzetta L, Rinaldi B, Cazzola M. Treatment of COPD: moving beyond the lungs. Curr Opin Pharmacol 2012; 12(3):315–22.Epub 2012 Apr 30.
   PubMed Web of Science ®Google Scholar